450 related articles for article (PubMed ID: 28101004)
1. Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease.
Kendall DA; Yudowski GA
Front Cell Neurosci; 2016; 10():294. PubMed ID: 28101004
[TBL] [Abstract][Full Text] [Related]
2. Behavioral effects of cannabinoid agents in animals.
Chaperon F; Thiébot MH
Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.
Galve-Roperh I; Chiurchiù V; Díaz-Alonso J; Bari M; Guzmán M; Maccarrone M
Prog Lipid Res; 2013 Oct; 52(4):633-50. PubMed ID: 24076098
[TBL] [Abstract][Full Text] [Related]
4. Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's Disease and Less Well-Known Diseases.
Páez JA; Campillo NE
Curr Med Chem; 2019; 26(18):3300-3340. PubMed ID: 29484980
[TBL] [Abstract][Full Text] [Related]
5. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
6. Components of Endocannabinoid Signaling System Are Expressed in the Perinatal Mouse Cerebellum and Required for Its Normal Development.
Martinez LR; Black KC; Webb BT; Bell A; Baygani SK; Mier TJ; Dominguez L; Mackie K; Kalinovsky A
eNeuro; 2020; 7(2):. PubMed ID: 32179579
[TBL] [Abstract][Full Text] [Related]
7. ENDOCANNABINOIDS RECEPTORS MEDIATED CENTRAL AND PERIPHERAL EFFECTS (REVIEW).
Ghonghadze M; Pachkoria K; Okujava M; Antelava N; Gongadze N
Georgian Med News; 2020 Jan; (298):137-143. PubMed ID: 32141867
[TBL] [Abstract][Full Text] [Related]
8. An Introduction to the Endogenous Cannabinoid System.
Lu HC; Mackie K
Biol Psychiatry; 2016 Apr; 79(7):516-25. PubMed ID: 26698193
[TBL] [Abstract][Full Text] [Related]
9. Structural and Functional Insights into Cannabinoid Receptors.
Li X; Shen L; Hua T; Liu ZJ
Trends Pharmacol Sci; 2020 Sep; 41(9):665-677. PubMed ID: 32739033
[TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Fride E
Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
[TBL] [Abstract][Full Text] [Related]
11. An Update on Non-CB
Morales P; Reggio PH
Cannabis Cannabinoid Res; 2017; 2(1):265-273. PubMed ID: 29098189
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
Svízenská I; Dubový P; Sulcová A
Pharmacol Biochem Behav; 2008 Oct; 90(4):501-11. PubMed ID: 18584858
[TBL] [Abstract][Full Text] [Related]
13. Role of endocannabinoids and cannabinoid CB1 receptors in alcohol-related behaviors.
Hungund BL; Basavarajappa BS
Ann N Y Acad Sci; 2004 Oct; 1025():515-27. PubMed ID: 15542757
[TBL] [Abstract][Full Text] [Related]
14. Analysis of natural product regulation of cannabinoid receptors in the treatment of human disease.
Badal S; Smith KN; Rajnarayanan R
Pharmacol Ther; 2017 Dec; 180():24-48. PubMed ID: 28583800
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications.
Onaivi ES
Int Rev Neurobiol; 2009; 88():335-69. PubMed ID: 19897083
[TBL] [Abstract][Full Text] [Related]
16. Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders.
Manera C; Arena C; Chicca A
Recent Pat CNS Drug Discov; 2016; 10(2):142-156. PubMed ID: 27193072
[TBL] [Abstract][Full Text] [Related]
17. Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases.
Chicca A; Arena C; Manera C
Recent Pat CNS Drug Discov; 2016; 10(2):122-141. PubMed ID: 27630088
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoids and neurodegenerative diseases.
Micale V; Mazzola C; Drago F
Pharmacol Res; 2007 Nov; 56(5):382-92. PubMed ID: 17950616
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoids, exercise, pain, and a path to health with aging.
Watkins BA
Mol Aspects Med; 2018 Dec; 64():68-78. PubMed ID: 30290200
[TBL] [Abstract][Full Text] [Related]
20. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
